MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer
MET改变是ALK阳性肺癌中一种反复出现且可靶向治疗的耐药机制
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-19-3906
Dagogo-Jack, Ibiayi; Yoda, Satoshi; Lennerz, Jochen K; Langenbucher, Adam; Lin, Jessica J; Rooney, Marguerite M; Prutisto-Chang, Kylie; Oh, Audris; Adams, Nathaniel A; Yeap, Beow Y; Chin, Emily; Do, Andrew; Marble, Hetal D; Stevens, Sara E; Digumarthy, Subba R; Saxena, Ashish; Nagy, Rebecca J; Benes, Cyril H; Azzoli, Christopher G; Lawrence, Michael S; Gainor, Justin F; Shaw, Alice T; Hata, Aaron N